Robert S. Landsman

Array ( [id] => 5539195 [patent_doc_number] => 20090221000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'METHODS OF QUANTIFYING TASTE OF COMPOUNDS FOR FOOD OR BEVERAGES' [patent_app_type] => utility [patent_app_number] => 12/270830 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 30196 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221000.pdf [firstpage_image] =>[orig_patent_app_number] => 12270830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977943 [patent_doc_number] => 08071719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Heteromeric taste receptors' [patent_app_type] => utility [patent_app_number] => 12/270834 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 30194 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071719.pdf [firstpage_image] =>[orig_patent_app_number] => 12270834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773716 [patent_doc_number] => 08119402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Methods of inhibiting T1R1/T1R3 heteromeric umami taste receptors' [patent_app_type] => utility [patent_app_number] => 12/270848 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 30203 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119402.pdf [firstpage_image] =>[orig_patent_app_number] => 12270848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104229 [patent_doc_number] => 08153763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Heteromeric T1R2/T1R3 taste receptors' [patent_app_type] => utility [patent_app_number] => 12/270813 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 30222 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153763.pdf [firstpage_image] =>[orig_patent_app_number] => 12270813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8163970 [patent_doc_number] => 08173373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Methods of screening T1R1/T1R3 heteromeric receptors for compounds that modulate umami taste signaling' [patent_app_type] => utility [patent_app_number] => 12/270846 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 30203 [patent_no_of_claims] => 114 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173373.pdf [firstpage_image] =>[orig_patent_app_number] => 12270846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305446 [patent_doc_number] => 08226976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Method of using cell-free protein synthesis to produce a membrane protein' [patent_app_type] => utility [patent_app_number] => 12/741575 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12313 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12741575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430995 [patent_doc_number] => 20100143360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR 2' [patent_app_type] => utility [patent_app_number] => 12/258109 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13354 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143360.pdf [firstpage_image] =>[orig_patent_app_number] => 12258109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397331 [patent_doc_number] => 20090317394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'VASCULAR ENDOTHELIAL GROWTH FACTOR-2' [patent_app_type] => utility [patent_app_number] => 12/258140 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 80735 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317394.pdf [firstpage_image] =>[orig_patent_app_number] => 12258140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533537 [patent_doc_number] => 20090233325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'SCREENING METHOD OF NESFATIN-1-ACTION REGULATING SUBSTANCE OR NESFATIN-1-LIKE ACTION SUBSTANCE WITH THE USE OF RECEPTOR PROTEIN SELECTED FROM THE GROUP CONSISTING OF GPR3, GPR6 AND GPR12' [patent_app_type] => utility [patent_app_number] => 12/257351 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15202 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233325.pdf [firstpage_image] =>[orig_patent_app_number] => 12257351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773574 [patent_doc_number] => 08119354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Cell-free assay product and method of use thereof for measuring activity of frizzled receptors' [patent_app_type] => utility [patent_app_number] => 12/682282 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10436 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119354.pdf [firstpage_image] =>[orig_patent_app_number] => 12682282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561818 [patent_doc_number] => 20100272732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'EMP2 ANTIBODIES AND THEIR THERAPEUTIC USES' [patent_app_type] => utility [patent_app_number] => 12/682032 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 38048 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272732.pdf [firstpage_image] =>[orig_patent_app_number] => 12682032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561818 [patent_doc_number] => 20100272732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'EMP2 ANTIBODIES AND THEIR THERAPEUTIC USES' [patent_app_type] => utility [patent_app_number] => 12/682032 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 38048 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272732.pdf [firstpage_image] =>[orig_patent_app_number] => 12682032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270890 [patent_doc_number] => 20100255007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'THERAPEUTIC AGENTS FOR GRAFT-VERSUS-HOST DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 12/733951 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8957 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255007.pdf [firstpage_image] =>[orig_patent_app_number] => 12733951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292936 [patent_doc_number] => 20100239652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'IMMUNOLIPOSOMES FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/680698 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23393 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239652.pdf [firstpage_image] =>[orig_patent_app_number] => 12680698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264964 [patent_doc_number] => 20090117649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'ISOLATED SOLUBLE CORTICOTROPIN RELEASING FACTOR RECEPTOR TYPE 2 (SCRFR2)' [patent_app_type] => utility [patent_app_number] => 12/236806 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25429 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117649.pdf [firstpage_image] =>[orig_patent_app_number] => 12236806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361604 [patent_doc_number] => 20090036398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Human G-Protein Coupled Receptor (HETGQ23)' [patent_app_type] => utility [patent_app_number] => 12/233178 [patent_app_country] => US [patent_app_date] => 2008-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12808 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036398.pdf [firstpage_image] =>[orig_patent_app_number] => 12233178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575930 [patent_doc_number] => 20090143292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Liquid Formulation of G-CSF Conjugate' [patent_app_type] => utility [patent_app_number] => 12/201705 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10447 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143292.pdf [firstpage_image] =>[orig_patent_app_number] => 12201705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338365 [patent_doc_number] => 20090054829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Electrogenic pump molecule control' [patent_app_type] => utility [patent_app_number] => 12/231030 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 40447 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054829.pdf [firstpage_image] =>[orig_patent_app_number] => 12231030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422924 [patent_doc_number] => 20090149379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'NOVEL USE OF CYTOKINE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/191474 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5201 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149379.pdf [firstpage_image] =>[orig_patent_app_number] => 12191474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10002454 [patent_doc_number] => 09046537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain' [patent_app_type] => utility [patent_app_number] => 12/221863 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9858 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12221863 [rel_patent_id] =>[rel_patent_doc_number] =>)